CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 700 enrolled
Drug / intervention
MORU in-house ELISA test followed by IFA if positiveother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03847870
NCT03847870N/ACompleted

Background Seroprevalence of Rickettsial Infections in Myanmar

Myanmar Oxford Clinical Research Unit·observational·Posted Feb 20, 2019·Updated Jan 13, 2020

In Brief

An observational study evaluating MORU in-house ELISA test followed by IFA if positive for Rickettsiae Infections. Completed, enrolled 700 participants across 1 site.

Detailed Summary

Rickettsial infections have been found to be the second most common cause of non-malarial febrile illness in Southeast Asia, just after dengue, and are largely neglected treatable causes of morbidity and mortality. The rickettsiae can be divided into three major groups: the scrub typhus group (STG), the typhus group (TG) and the spotted fever group (SFG). Rickettsial infections typically present with an acute fever and are difficult to diagnose due to the many different causes of undifferentiated fever in Southeast Asia. Rickettsial IgG seroprevalence, reflecting past infection, will give an estimate of the burden of rickettsial infections in the population. Background seroprevalence studies in countries around Myanmar have found high rates of rickettsial infections. Yet, in Myanmar there have been no prevalence studies on rickettsial infections since the Second World War. We plan to determine IgG levels to the three different groups of rickettsial infections in leftover blood samples in several clinics and hospitals in different regions of Myanmar.

Study Details

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 20, 2019
Enrollment StartJun 20, 2019
Primary CompletionOct 25, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.4 years ago

Interventions

MORU in-house ELISA test followed by IFA if positiveother

An in-house rickettsial IgG ELISA test will be used for this study to determine previous rickettsial infections by measuring IgG levels. All specimens will be tested for IgG antibodies using ELISA tests for scrub typhus (Orientia tsutsugamushi strains Karp, Kato, Gilliam and TA716), murine typhus (Rickettsia typhi strain type Wilmington), and spotted fever rickettsiosis (Rickettsia honei and Rickettsia conorii). If the sample tests positive, it will be retested for the same antigens using the IFA test. The sample will be considered positive if both the ELISA and the IFA are positive.